These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

206 related articles for article (PubMed ID: 29927068)

  • 21. Understanding the challenges of protein flexibility in drug design.
    Antunes DA; Devaurs D; Kavraki LE
    Expert Opin Drug Discov; 2015 Dec; 10(12):1301-13. PubMed ID: 26414598
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Binding Free Energy Calculation Using Quantum Mechanics Aimed for Drug Lead Optimization.
    Cavasotto CN
    Methods Mol Biol; 2020; 2114():257-268. PubMed ID: 32016898
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Toward on-the-fly quantum mechanical/molecular mechanical (QM/MM) docking: development and benchmark of a scoring function.
    Chaskar P; Zoete V; Röhrig UF
    J Chem Inf Model; 2014 Nov; 54(11):3137-52. PubMed ID: 25296988
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Structure-based virtual screening approach for discovery of covalently bound ligands.
    Toledo Warshaviak D; Golan G; Borrelli KW; Zhu K; Kalid O
    J Chem Inf Model; 2014 Jul; 54(7):1941-50. PubMed ID: 24932913
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Using reverse docking for target identification and its applications for drug discovery.
    Lee A; Lee K; Kim D
    Expert Opin Drug Discov; 2016 Jul; 11(7):707-15. PubMed ID: 27186904
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Ligand-Receptor Interactions and Drug Design.
    Syriopoulou A; Markopoulos I; Tzakos AG; Mavromoustakos T
    Methods Mol Biol; 2021; 2266():89-104. PubMed ID: 33759122
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Empirical Scoring Functions for Affinity Prediction of Protein-ligand Complexes.
    Pason LP; Sotriffer CA
    Mol Inform; 2016 Dec; 35(11-12):541-548. PubMed ID: 27870243
    [TBL] [Abstract][Full Text] [Related]  

  • 28. CovalentDock: automated covalent docking with parameterized covalent linkage energy estimation and molecular geometry constraints.
    Ouyang X; Zhou S; Su CT; Ge Z; Li R; Kwoh CK
    J Comput Chem; 2013 Feb; 34(4):326-36. PubMed ID: 23034731
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Machine-learning methods for ligand-protein molecular docking.
    Crampon K; Giorkallos A; Deldossi M; Baud S; Steffenel LA
    Drug Discov Today; 2022 Jan; 27(1):151-164. PubMed ID: 34560276
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Covalent docking of large libraries for the discovery of chemical probes.
    London N; Miller RM; Krishnan S; Uchida K; Irwin JJ; Eidam O; Gibold L; Cimermančič P; Bonnet R; Shoichet BK; Taunton J
    Nat Chem Biol; 2014 Dec; 10(12):1066-72. PubMed ID: 25344815
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Selective and Effective: Current Progress in Computational Structure-Based Drug Discovery of Targeted Covalent Inhibitors.
    Bianco G; Goodsell DS; Forli S
    Trends Pharmacol Sci; 2020 Dec; 41(12):1038-1049. PubMed ID: 33153778
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Protocol for rational design of covalently interacting inhibitors.
    Schmidt TC; Welker A; Rieger M; Sahu PK; Sotriffer CA; Schirmeister T; Engels B
    Chemphyschem; 2014 Oct; 15(15):3226-35. PubMed ID: 25251382
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Aromatic interactions at the ligand-protein interface: Implications for the development of docking scoring functions.
    Brylinski M
    Chem Biol Drug Des; 2018 Feb; 91(2):380-390. PubMed ID: 28816025
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Virtual screening: an in silico tool for interlacing the chemical universe with the proteome.
    Westermaier Y; Barril X; Scapozza L
    Methods; 2015 Jan; 71():44-57. PubMed ID: 25193260
    [TBL] [Abstract][Full Text] [Related]  

  • 35. User-Friendly Quantum Mechanics: Applications for Drug Discovery.
    Kotev M; Sarrat L; Gonzalez CD
    Methods Mol Biol; 2020; 2114():231-255. PubMed ID: 32016897
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Large scale free energy calculations for blind predictions of protein-ligand binding: the D3R Grand Challenge 2015.
    Deng N; Flynn WF; Xia J; Vijayan RS; Zhang B; He P; Mentes A; Gallicchio E; Levy RM
    J Comput Aided Mol Des; 2016 Sep; 30(9):743-751. PubMed ID: 27562018
    [TBL] [Abstract][Full Text] [Related]  

  • 37. QM Implementation in Drug Design: Does It Really Help?
    Liu J; He X
    Methods Mol Biol; 2020; 2114():19-35. PubMed ID: 32016884
    [TBL] [Abstract][Full Text] [Related]  

  • 38. MTiOpenScreen: a web server for structure-based virtual screening.
    Labbé CM; Rey J; Lagorce D; Vavruša M; Becot J; Sperandio O; Villoutreix BO; Tufféry P; Miteva MA
    Nucleic Acids Res; 2015 Jul; 43(W1):W448-54. PubMed ID: 25855812
    [TBL] [Abstract][Full Text] [Related]  

  • 39. AutoDockFR: Advances in Protein-Ligand Docking with Explicitly Specified Binding Site Flexibility.
    Ravindranath PA; Forli S; Goodsell DS; Olson AJ; Sanner MF
    PLoS Comput Biol; 2015 Dec; 11(12):e1004586. PubMed ID: 26629955
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Theory and applications of covalent docking in drug discovery: merits and pitfalls.
    Kumalo HM; Bhakat S; Soliman ME
    Molecules; 2015 Jan; 20(2):1984-2000. PubMed ID: 25633330
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.